The president-elect also named Jim O’Neill, a Silicon Valley investor and former federal health official, to be deputy secretary of Health and Human Services. View original article Contributor: Dan Diamond
Today’s newsletter: Hospitals find lasting workarounds on IV fluid shortages. Pandemic response critic named to lead NIH, and more. View original article Contributor: Jackie Fortiér, McKenzie Beard
The landmark move is expected to shorten wait times for organs for all patients and reduce hurdles to life-saving care for those with HIV. View original article Contributor: Anumita Kaur
Experts worry that the unenthusiastic embrace of vaccines could spark outbreaks and increased hospitalizations. View original article Contributor: Sabrina Malhi
Will a new conservative tide in Miami-Dade County wash fluoride out of the drinking water, too? Florida’s top health official under Gov. Ron DeSantis last week recommended local governments stop … Click to Continue » View original article Contributor:
Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes. View original article Contributor: Rebecca Robbins, Christina Jewett and Kate Kelly
When it comes to weeding out corporate influence, Robert F. Kennedy Jr.’s ideas often align best with some of Trump’s loudest critics. View original article Contributor: Emily Baumgaertner
It’s the season for sniffles and sore throats, which means that scientists are monitoring the usual suspects like influenza, RSV, and COVID-19. But they’re also watching another virus this winter: H5N1 avian influenza, or bird flu. U.S. health agencies say that the virus currently poses a low risk to the general public, even though it … Read more
Holiday season means food—and a lot of it, from work events to social gatherings with friends and family. “When I talk to my patients, instead of calling it the most beautiful time of year, I call it the most challenging time of the year,” says Dr. Andres Acosta, a physician in the division of gastroenterology … Read more
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden administration said. View original article Contributor: Dan Diamond